Absorption through Intestinal Epithelium as Influenced by Phospholipids

  • Ruth R. Levine
  • Phyllis J. Kornguth
Conference paper


Quaternary ammonium compounds, organic cations at all physiologic pH’s, were found to be absorbed incompletely but fairly rapidly from the intestine, in vivo (Levine 1960, Levine et al. 1955). In the case of a proto-typic monoquaternary agent, benzomethamine, detailed kinetic studies showed that more than passive diffusion was involved in this absorption (Levine and Pelikan 1961). This work led to the formulation of the hypothesis that some of the quaternary compound was transferred as the neutral complex by virtue of combination with an endogenous anion. Upon testing this hypothesis, a fraction of tissue, the phosphatido-peptide fraction (Folch 1952) was found to have a significant and dose-dependent effect in increasing the degree of intestinal absorption of various quaternary ammonium compounds (Levine and Spencer 1961, Levine 1962, 1963). Kinetic studies of the absorption of benzomethamine in the presence of the phosphatido-peptide fraction have yielded data which permit the inference that the absorption of benzomethamine even in the presence of this fraction does not occur by passive (diffusion alone (Levine and Pelican 1964). The data to be reported here are results of studies undertaken to determine the mechanism by which the phosphatido-peptide fraction produces its effect on the absorption of the protottypic agent, benzomethamine.


Intestinal Epithelium Organic Cation Intestinal Tissue Ammonium Compound Quaternary Ammonium Compound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Folch, J., 1952: In: W. D. Elroy and B. Glass, Phosphorus metabolism, II, Johns Hopkins Press, p. 186.Google Scholar
  2. Huggins, C. G., and D. V. Cohn, 1959: J. Biol. Chem. 234, 257–261.PubMedGoogle Scholar
  3. Levine, R. R., 1960: J. Pharmacol. & Exper. Therap. 129, 296–304.Google Scholar
  4. Levine, R. R., 1962: International Congress Series, No. 48, 2, 601.Google Scholar
  5. Levine, R. R., 1963: Fed. Proc. 22, 310.Google Scholar
  6. Levine, R. R., M. R. Blair, and B. B. Clark, 1955: J. Pharmacol. & Exper. Therap. 114, 78–86.Google Scholar
  7. Levine, R. R., and E. W. Pelikan, 1961: J. Pharmacol. & Exper. Therap. 131, 319–327.Google Scholar
  8. Levine, R. R., 1964: Ann. Rev. Pharmacol. 4, 69–84.CrossRefGoogle Scholar
  9. Levine, R. R., and A. F. Spencer, 1961: Biochem. Pharmacol. 8, 248–250.PubMedCrossRefGoogle Scholar
  10. Mitchell, R. R. (Levine), and B. B. Clark, 1952: Proc. Soc. Exper. Biol. & Med. 81, 105–109.Google Scholar

Copyright information

© Springer-Verlag/Wien 1967

Authors and Affiliations

  • Ruth R. Levine
    • 1
  • Phyllis J. Kornguth
    • 1
  1. 1.Department of Pharmacology, Boston University Medical CenterBoston University School of MedicineBostonUSA

Personalised recommendations